Cargando…
Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate
The therapeutic options for patients with metastatic renal cell carcinoma (mRCC) have completely changed during the last ten years. With the sequential use of targeted therapies, median overall survival has increased in daily practice and now it is not uncommon to see patients surviving kidney cance...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385431/ https://www.ncbi.nlm.nih.gov/pubmed/28439491 http://dx.doi.org/10.5306/wjco.v8.i2.100 |